AP2015008270A0 - Preparation for the treatment of tuberculosis - Google Patents
Preparation for the treatment of tuberculosisInfo
- Publication number
- AP2015008270A0 AP2015008270A0 AP2015008270A AP2015008270A AP2015008270A0 AP 2015008270 A0 AP2015008270 A0 AP 2015008270A0 AP 2015008270 A AP2015008270 A AP 2015008270A AP 2015008270 A AP2015008270 A AP 2015008270A AP 2015008270 A0 AP2015008270 A0 AP 2015008270A0
- Authority
- AP
- ARIPO
- Prior art keywords
- tuberculosis
- preparation
- treatment
- Prior art date
Links
- 201000008827 tuberculosis Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Organic Chemistry (AREA)
- Pulmonology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UA201208962 | 2012-07-20 | ||
PCT/UA2013/000079 WO2014014434A1 (en) | 2012-07-20 | 2013-07-22 | Preparation for the treatment of tuberculosis |
Publications (1)
Publication Number | Publication Date |
---|---|
AP2015008270A0 true AP2015008270A0 (en) | 2015-02-28 |
Family
ID=56889302
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AP2015008270A AP2015008270A0 (en) | 2012-07-20 | 2013-07-22 | Preparation for the treatment of tuberculosis |
Country Status (6)
Country | Link |
---|---|
AP (1) | AP2015008270A0 (en) |
BR (1) | BR112015001275A2 (en) |
EA (1) | EA025861B1 (en) |
RU (1) | RU2648822C2 (en) |
UA (1) | UA74095U (en) |
WO (1) | WO2014014434A1 (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6495534B2 (en) * | 2000-05-15 | 2002-12-17 | Pharmacia & Upjohn Spa | Stabilized aqueous suspensions for parenteral use |
CN102458421A (en) * | 2009-05-28 | 2012-05-16 | 欧布谢斯特沃公司 | Pharmaceutical agents |
-
2012
- 2012-07-20 UA UAU201208962U patent/UA74095U/en unknown
-
2013
- 2013-07-22 RU RU2015106366A patent/RU2648822C2/en not_active IP Right Cessation
- 2013-07-22 AP AP2015008270A patent/AP2015008270A0/en unknown
- 2013-07-22 BR BR112015001275-2A patent/BR112015001275A2/en not_active IP Right Cessation
- 2013-07-22 EA EA201590243A patent/EA025861B1/en not_active IP Right Cessation
- 2013-07-22 WO PCT/UA2013/000079 patent/WO2014014434A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
RU2648822C2 (en) | 2018-03-28 |
UA74095U (en) | 2012-10-10 |
EA201590243A1 (en) | 2015-06-30 |
RU2015106366A (en) | 2016-09-10 |
BR112015001275A2 (en) | 2018-01-30 |
WO2014014434A1 (en) | 2014-01-23 |
EA025861B1 (en) | 2017-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2906208A4 (en) | Therapeutic treatment | |
EP2867209A4 (en) | Compounds and therapeutic uses thereof | |
HK1211480A1 (en) | External preparation for skin | |
SI2812013T1 (en) | Formulation for the treatment of ibs | |
ZA201504167B (en) | Processes for the preparation of 4-amino-3-halo-6- (substituted)picolinates and 4-amino-5-fluoro-3-halo-6- (substituted)picolinates | |
PL399418A1 (en) | Process for the preparation of 4-methoxydihydrochalcone | |
PL399419A1 (en) | Process for the preparation of 4-methoxydihydrochalcone | |
IL236450A0 (en) | Process for the preparation of 5-fluoro-1h-pyrazoles | |
ZA201501038B (en) | Treatment of wax | |
IL234796B (en) | Compounds for the treatment of ischemia-reperfusion-related diseases | |
EP2804853A4 (en) | Therapeutic uses | |
GB201207907D0 (en) | Treatment of depression | |
HK1210421A1 (en) | Use of pregn-4-en-20-yn-3-one for the treatment of depressive disorders -4--20--3- | |
AP2015008270A0 (en) | Preparation for the treatment of tuberculosis | |
IL236873A0 (en) | Therapeutic compounds | |
HUP1200675A2 (en) | Process for the preparation of pyrimidinyl-piperazines | |
GB201221118D0 (en) | Methods of treatment | |
GB201216740D0 (en) | Methods of treatment | |
GB201216748D0 (en) | Methods of treatment | |
GB201206325D0 (en) | Methods of treatment | |
GB201206330D0 (en) | Methods of treatment | |
GB201206324D0 (en) | Methods of treatment | |
GB201206326D0 (en) | Methods of treatment | |
GB201211135D0 (en) | Treatment | |
GB201208690D0 (en) | Treatment |